Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02TKC
|
||||
Former ID |
DNC009763
|
||||
Drug Name |
1,2-Diacetoxylycorine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530120] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H21NO6
|
||||
Canonical SMILES |
CC(=O)OC1C=C2CCN3C2C(C1OC(=O)C)C4=CC5=C(C=C4C3)OCO5
|
||||
InChI |
1S/C20H21NO6/c1-10(22)26-17-5-12-3-4-21-8-13-6-15-16(25-9-24-15)7-14(13)18(19(12)21)20(17)27-11(2)23/h5-7,17-20H,3-4,8-9H2,1-2H3/t17-,18-,19+,20+/m0/s1
|
||||
InChIKey |
LMZHAKUXAHOCST-VNTMZGSJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 3A4 | Target Info | Inhibitor | [530120] | |
PathWhiz Pathway | Caffeine Metabolism | ||||
Retinol Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Aflatoxin B1 metabolism | |||||
Estrogen metabolism | |||||
Benzo(a)pyrene metabolism | |||||
Tamoxifen metabolism | |||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Nuclear Receptors Meta-Pathway | |||||
Farnesoid X Receptor Pathway | |||||
Vitamin D Receptor Pathway | |||||
Felbamate Metabolism | |||||
Lidocaine metabolism | |||||
Nifedipine Activity | |||||
Colchicine Metabolic Pathway | |||||
Irinotecan Pathway | |||||
Drug Induction of Bile Acid Pathway | |||||
Fatty Acid Omega Oxidation | |||||
Codeine and Morphine Metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.